Natural Killer Cells Therapeutics Market By Type (NK Cell Therapies and Antibody Directed NK Cell Therapies); By Therapeutic Indication (Cancer, Viral Infections, Autoimmune Diseases, Neurodegenerative Diseases, and Others); By Source (Peripheral Blood, Umbilical Cord Blood, Induced Pluripotent Natural killer cells therapeutics (iPSC), and Others); By End User (Hospitals & Clinics, Research Institutes, and Others); By Region (U.S., Canada, Mexico, Rest of North America, The UK, France, Germany, Italy, Spain, Nordic Countries (Denmark, Finland, Iceland, Sweden, Norway), Benelux Union (Belgium, the Netherlands, Luxembourg), Rest of Europe, China, Japan, India, New Zealand, Australia, South Korea, Southeast Asia (Indonesia, Thailand, Malaysia, Singapore, Rest of Southeast Asia), Saudi Arabia, UAE, Egypt, Kuwait, South Africa, Rest of Middle East & Africa, Brazil, Argentina, Rest of Latin America); – Global Insights, Growth, Size, Comparative Analysis, Trends and Forecast, 2021 - 2029

Report ID :AMI-862 | Category : Healthcare | Published Date : July, 2021 | Pages : 402 | Format :PDF